Sleep and Neuromuscular Disease

ABSTRACT

Sleep disorders in patients with neuromuscular disease are common, but underrecognized by health care providers, and sometimes by patients themselves. Their symptoms may be confused with those of the underlying disease. Their recognition is an important part of the management of patients with neuromuscular disorders, improving quality of life, and sometimes increasing survival. Inadequate ventilation underlies many sleep disorders, and sleep-related disorders may presage daytime ventilatory disorders with disease progression. Involvement of the central or peripheral nervous system, or both, may disrupt sleep, with the relative contribution of each depending on the specific disorder. The pertinent anatomy, physiology, and clinical features of sleep disorders in neuromuscular diseases and a basic approach to their assessment is discussed. Specific neuromuscular disorders in which sleep is commonly affected are reviewed and the principles of management of sleep disorders summarized.

KEYWORDS

Sleep - neuromuscular - respiratory - myasthenia - myopathy - neuropathy

REFERENCES

• 1 Desai H, Mador J. Sleep in patients with respiratory muscle weakness.  Sleep Med Clin. 2008;  3 541-550
• 2 Labanowski M, Schmidt-Nowara W, Guilleminault C. Sleep and neuromuscular disease: frequency of sleep-disordered breathing in a neuromuscular disease clinic population.  Neurology. 1996;  47(5) 1173-1180
• 3 Benditt J O. The neuromuscular respiratory system: physiology, pathophysiology, and a respiratory care approach to patients.  Respir Care. 2006;  51(8) 829-837 discussion 837-839
• 4 Chokroverty S. Sleep-disordered breathing in neuromuscular disorders: a condition in search of recognition.  Muscle Nerve. 2001;  24(4) 451-455
• 5 Horner R L. Pathophysiology of obstructive sleep apnea.  J Cardiopulm Rehabil Prev. 2008;  28(5) 289-298
• 6 Guilleminault C, Shergill R P. Sleep-disordered breathing in neuromuscular disease.  Curr Treat Options Neurol. 2002;  4(2) 107-112
• 7 Happe S. Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management.  Drugs. 2003;  63(24) 2725-2737
• 8 Bourke S C, Gibson G J. Sleep and breathing in neuromuscular disease.  Eur Respir J. 2002;  19(6) 1194-1201
• 9 Oztura I, Guilleminault C. Neuromuscular disorders and sleep.  Curr Neurol Neurosci Rep. 2005;  5(2) 147-152
• 10 Van Lunteren E, Kaminski H J. Disorders of sleep and breathing during sleep in neuromuscular disease.  Sleep Breath. 1999;  3(1) 23-30
• 11 Brooks S N. Neuromuscular disorders and sleepiness.  Sleep Med Clin. 2006;  1 119-125
• 12 Baumann C R, Bassetti C L. CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies.  Neurology. 2004;  62(12) 2337 , author reply 2337
• 13 Cochen V, Arnulf I, Demeret S et al.. Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome.  Brain. 2005;  128(Pt 11) 2535-2545
• 14 Fronczek R, Baumann C R, Lammers G J, Bassetti C L, Overeem S. Hypocretin/orexin disturbances in neurological disorders.  Sleep Med Rev. 2009;  13(1) 9-22
• 15 Martínez-Rodríguez J E, Lin L, Iranzo A et al.. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.  Sleep. 2003;  26(3) 287-290
• 16 Nishino S, Kanbayashi T, Fujiki N et al.. CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies.  Neurology. 2003;  61(6) 823-825
• 17 Culebras A. Sleep-disordered breathing in neuromuscular disease.  Sleep Med Clin. 2008;  3 377-386
• 18 Piper A. Sleep abnormalities associated with neuromuscular disease: pathophysiology and evaluation.  Semin Respir Crit Care Med. 2002;  23(3) 211-219
• 19 Piper A. Sleep and quality of life in neuromuscular disease. In: Verster JC Sleep and Quality of Life in Clinical Medicine. Totowa, NJ; Humana Press 2008: 209-220
• 20 Yumino D, Kasanuki H. Sleep apnea and the heart: diagnosis and treatment.  Rev Cardiovasc Med. 2008;  9(3) 159-167
• 21 Guilleminault C, Brooks S N. Excessive daytime sleepiness: a challenge for the practising neurologist.  Brain. 2001;  124(Pt 8) 1482-1491
• 22 Maislin G, Pack A I, Kribbs N B et al.. A survey screen for prediction of apnea.  Sleep. 1995;  18(3) 158-166
• 23 Mehta S. Neuromuscular disease causing acute respiratory failure.  Respir Care. 2006;  51(9) 1016-1021 discussion 1021-1023
• 24 Phillips M F, Smith P E, Carroll N, Edwards R H, Calverley P M. Nocturnal oxygenation and prognosis in Duchenne muscular dystrophy.  Am J Respir Crit Care Med. 1999;  160(1) 198-202
• 25 Bourke S C, Shaw P J, Gibson G J. Respiratory function vs sleep-disordered breathing as predictors of QOL in ALS.  Neurology. 2001;  57(11) 2040-2044
• 26 Corcia P, Meininger V. Management of amyotrophic lateral sclerosis.  Drugs. 2008;  68(8) 1037-1048
• 27 Arnulf I, Similowski T, Salachas F et al.. Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis.  Am J Respir Crit Care Med. 2000;  161(3 Pt 1) 849-856
• 28 Gay P C, Westbrook P R, Daube J R, Litchy W J, Windebank A J, Iverson R. Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis.  Mayo Clin Proc. 1991;  66(7) 686-694
• 29 Ferguson K A, Strong M J, Ahmad D, George C F. Sleep-disordered breathing in amyotrophic lateral sclerosis.  Chest. 1996;  110(3) 664-669
• 30 Bourke S C, Tomlinson M, Williams T L, Bullock R E, Shaw P J, Gibson G J. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.  Lancet Neurol. 2006;  5(2) 140-147
• 31 Peysson S, Vandenberghe N, Philit F et al.. Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis.  Eur Neurol. 2008;  59(3-4) 164-171
• 32 Bourke S C, Bullock R E, Williams T L, Shaw P J, Gibson G J. Noninvasive ventilation in ALS: indications and effect on quality of life.  Neurology. 2003;  61(2) 171-177
• 33 Van Rooij F G, Jurgen Schelhaas H, Lammers G J, Verbeek M M, Overeem S. CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis.  Amyotroph Lateral Scler. 2008;  , August 7 (Epub ahead of print)
• 34 Gustorff B, Dorner T, Likar R et al.. Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey.  Acta Anaesthesiol Scand. 2008;  52(1) 132-136
• 35 Ziegler D. Painful diabetic neuropathy: treatment and future aspects.  Diabetes Metab Res Rev. 2008;  24(Suppl 1) S52-S57
• 36 Dziewas R, Waldmann N, Böntert M et al.. Increased prevalence of obstructive sleep apnoea in patients with Charcot-Marie-Tooth disease: a case control study.  J Neurol Neurosurg Psychiatry. 2008;  79(7) 829-831
• 37 Vernon M K, Brandenburg N A, Alvir J M, Griesing T, Revicki D A. Reliability, validity, and responsiveness of the daily sleep interference scale among diabetic peripheral neuropathy and postherpetic neuralgia patients.  J Pain Symptom Manage. 2008;  36(1) 54-68
• 38 Galer B S, Gianas A, Jensen M P. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life.  Diabetes Res Clin Pract. 2000;  47(2) 123-128
• 39 Koeppen S, Kraywinkel K, Wessendorf T E et al.. Long-term outcome of Guillain-Barré syndrome.  Neurocrit Care. 2006;  5(3) 235-242
• 40 Dematteis M, Pépin J L, Jeanmart M, Deschaux C, Labarre-Vila A, Lévy P. Charcot-Marie-Tooth disease and sleep apnoea syndrome: a family study.  Lancet. 2001;  357(9252) 267-272
• 41 Dziewas R, Schilling M, Engel P et al.. Treatment for obstructive sleep apnoea: effect on peripheral nerve function.  J Neurol Neurosurg Psychiatry. 2007;  78(3) 295-297
• 42 Mayer P, Dematteis M, Pépin J L et al.. Peripheral neuropathy in sleep apnea. A tissue marker of the severity of nocturnal desaturation.  Am J Respir Crit Care Med. 1999;  159(1) 213-219
• 43 Nicolle M W. Myasthenia gravis.  Neurologist. 2002;  8(1) 2-21
• 44 Greim B, Engel C, Apel A, Zettl U K. Fatigue in neuroimmunological diseases.  J Neurol. 2007;  254(Suppl 2) II102-II106
• 45 Jaretzki III A, Barohn R J, Ernstoff R M Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America et al. Myasthenia gravis: recommendations for clinical research standards.  Neurology. 2000;  55(1) 16-23
• 46 Nicolle M W, Rask S, Koopman W J, George C F, Adams J, Wiebe S. Sleep apnea in patients with myasthenia gravis.  Neurology. 2006;  67(1) 140-142
• 47 Amino A, Shiozawa Z, Nagasaka T et al.. Sleep apnoea in well-controlled myasthenia gravis and the effect of thymectomy.  J Neurol. 1998;  245(2) 77-80
• 48 Quera-Salva M A, Guilleminault C, Chevret S et al.. Breathing disorders during sleep in myasthenia gravis.  Ann Neurol. 1992;  31(1) 86-92
• 49 Stepansky R, Weber G, Zeitlhofer J. Sleep apnea and cognitive dysfunction in myasthenia gravis.  Acta Med Austriaca. 1997;  24(3) 128-131
• 50 Papazian O. Rapid eye movement sleep alterations in myasthenia gravis.  Neurology. 1976;  26(4) 311-316
• 51 Manni R, Piccolo G, Sartori I et al.. Breathing during sleep in myasthenia gravis.  Ital J Neurol Sci. 1995;  16(9) 589-594
• 52 van Lunteren E, Moyer M, Kaminski H J. Adverse effects of myasthenia gravis on rat phrenic diaphragm contractile performance.  J Appl Physiol. 2004;  97(3) 895-901
• 53 Keenan S P, Alexander D, Road J D, Ryan C F, Oger J, Wilcox P G. Ventilatory muscle strength and endurance in myasthenia gravis.  Eur Respir J. 1995;  8(7) 1130-1135
• 54 Ringqvist I, Ringqvist T. Respiratory mechanics in untreated myasthenia gravis with special reference to the respiratory forces.  Acta Med Scand. 1971;  190(6) 499-508
• 55 Mier-Jedrzejowicz A K, Brophy C, Green M. Respiratory muscle function in myasthenia gravis.  Am Rev Respir Dis. 1988;  138(4) 867-873
• 56 Keesey J C. Does myasthenia gravis affect the brain?.  J Neurol Sci. 1999;  170(2) 77-89
• 57 Whiting P J, Cooper J, Lindstrom J M. Antibodies in sera from patients with myasthenia gravis do not bind to nicotinic acetylcholine receptors from human brain.  J Neuroimmunol. 1987;  16(2) 205-213
• 58 Rubinsztein J S, Rubinsztein D C, Goodburn S, Holland A J. Apathy and hypersomnia are common features of myotonic dystrophy.  J Neurol Neurosurg Psychiatry. 1998;  64(4) 510-515
• 59 Talbot K, Stradling J, Crosby J, Hilton-Jones D. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.  Neuromuscul Disord. 2003;  13(5) 357-364
• 60 van der Meché F G, Bogaard J M, van der Sluys J C, Schimsheimer R J, Ververs C C, Busch H F. Daytime sleep in myotonic dystrophy is not caused by sleep apnoea.  J Neurol Neurosurg Psychiatry. 1994;  57(5) 626-628
• 61 Laberge L, Bégin P, Montplaisir J, Mathieu J. Sleep complaints in patients with myotonic dystrophy.  J Sleep Res. 2004;  13(1) 95-100
• 62 MacDonald J R, Hill J D, Tarnopolsky M A. Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy.  Neurology. 2002;  59(12) 1876-1880
• 63 Giubilei F, Antonini G, Bastianello S et al.. Excessive daytime sleepiness in myotonic dystrophy.  J Neurol Sci. 1999;  164(1) 60-63
• 64 Cirignotta F, Mondini S, Zucconi M et al.. Sleep-related breathing impairment in myotonic dystrophy.  J Neurol. 1987;  235(2) 80-85
• 65 Ciafaloni E, Mignot E, Sansone V et al.. The hypocretin neurotransmission system in myotonic dystrophy type 1.  Neurology. 2008;  70(3) 226-230
• 66 Kumar R. Approved and investigational uses of modafinil: an evidence-based review.  Drugs. 2008;  68(13) 1803-1839
• 67 Annane D, Moore D H, Barnes P R, Miller R G. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.  Cochrane Database Syst Rev. 2006;  3 CD003218
• 68 Alves R S, Resende M B, Skomro R P, Souza F J, Reed U C. Sleep and neuromuscular disorders in children.  Sleep Med Rev. 2009;  13(2) 133-148
• 69 Suresh S, Wales P, Dakin C, Harris M A, Cooper D G. Sleep-related breathing disorder in Duchenne muscular dystrophy: disease spectrum in the paediatric population.  J Paediatr Child Health. 2005;  41(9-10) 500-503
• 70 Khan Y, Heckmatt J Z. Obstructive apnoeas in Duchenne muscular dystrophy.  Thorax. 1994;  49(2) 157-161
• 71 Mellies U, Ragette R, Schwake C, Baethmann M, Voit T, Teschler H. Sleep-disordered breathing and respiratory failure in acid maltase deficiency.  Neurology. 2001;  57(7) 1290-1295
• 72 Tölle T, Freynhagen R, Versavel M, Trostmann U, Young Jr J PJ. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.  Eur J Pain. 2008;  12(2) 203-213
• 73 Tölle T, Xu X, Sadosky A B. Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns.  J Diabetes Complications. 2006;  20(1) 26-33
• 74 Ozsancak A, D'Ambrosio C, Hill N S. Nocturnal noninvasive ventilation.  Chest. 2008;  133(5) 1275-1286
• 75 Robert D, Argaud L. Clinical review: long-term noninvasive ventilation.  Crit Care. 2007;  11(2) 210 Available at: http://ccforum.com/content/11/2/210 Accessed December 22, 2008; 
• 76 Annane D, Orlikowski D, Chevret S, Chevrolet J C, Raphaël J C. Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders.  Cochrane Database Syst Rev. 2007;  (4) CD001941
• 77 Veasey S C, Guilleminault C, Strohl K P, Sanders M H, Ballard R D, Magalang U J. Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine.  Sleep. 2006;  29(8) 1036-1044
• 78 Miyamoto T, Miyamoto M, Suga T, Aizawa C, Takekawa H, Hirata K. Methylphenidate hydrochloride for excessive daytime sleepiness in a patient with myotonic dystrophy.  Psychiatry Clin Neurosci. 2002;  56(3) 271-272
• 79 Damian M S, Gerlach A, Schmidt F, Lehmann E, Reichmann H. Modafinil for excessive daytime sleepiness in myotonic dystrophy.  Neurology. 2001;  56(6) 794-796